Intuitive Surgical, Inc. $ISRG Shares Sold by E. Ohman J or Asset Management AB

E. Ohman J or Asset Management AB reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.8% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 27,183 shares of the medical equipment provider’s stock after selling 1,676 shares during the period. E. Ohman J or Asset Management AB’s holdings in Intuitive Surgical were worth $14,772,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of ISRG. Chilton Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Global Financial Private Client LLC raised its position in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 38 shares during the period. Elite Financial Inc. acquired a new position in Intuitive Surgical during the first quarter worth $26,000. LFA Lugano Financial Advisors SA acquired a new position in Intuitive Surgical during the first quarter worth $30,000. Finally, TD Capital Management LLC boosted its position in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Piper Sandler reiterated an “overweight” rating and issued a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Evercore ISI boosted their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 8th. Truist Financial raised their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Finally, UBS Group increased their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a report on Wednesday, July 23rd. Thirteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $595.95.

Intuitive Surgical Stock Down 1.4%

ISRG stock opened at $449.68 on Monday. The business has a 50 day moving average price of $485.67 and a 200 day moving average price of $507.82. The stock has a market cap of $161.20 billion, a price-to-earnings ratio of 62.72, a PEG ratio of 4.71 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm’s revenue was up 21.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.78 earnings per share. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the sale, the director directly owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 in the last ninety days. Insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.